The first phase of a new vaccine trial was launched in Oxford last week in a bid to boost
international efforts to find a vaccine against HIV. The trials are sponsored by the …

Malaria sickens roughly 200 million people each year and kills more than 600,000, most in
sub-Saharan Africa. Yet the initial regulatory review of the first vaccine to prevent malaria …

S48| Nature| Vol 612| 22/29 December 2022| Corrected 19 January 2023© 2022 Springer
Nature Li mited. All rights reserved. efficacy of medicines and vaccines destined for low-and …

“The international community has a responsibility to recognise malaria, like the AIDS
pandemic, as a major challenge and to commit itself to do more to prevent the disaster that …

EDITOR—Whittle et al report one of the few long term follow up studies of children
vaccinated against hepatitis B. 1 The reported reduction in the rate of carriers of hepatitis B …

Two research programmes into a vaccine for HIV, costing£ 5.6 m ($9 m) and involving
partnerships between British, American, and African researchers, were launched last week …

A vast phase III clinical trial in Africa of the malaria vaccine candidate RTS, S/AS01 reported
disappointing results this morning. The vaccine failed to show substantial protection in the …

HIV infections and deaths from AIDS continue to ravage many countries around the world,
with most infected people living in the poorest nations. 1 In terms of morbidity and mortality …

In a letter to NHS trusts, integrated care boards, and royal medical colleges, NHS England
and the UK Health Security Agency said that eligible adults will be offered a single dose of …

Perils of launching a new vaccination campaign | The BMJ Skip to main content Intended for
healthcare professionals Access provided by Google Indexer Subscribe My Account My email …